Delphia Therapeutics focuses on developing new cancer medicines through its activation lethality platform, aiming to address resistance to traditional targeted therapies.
investor of
competitor of
Metrics
marketPRIVATE
msh_idCOM:DELPHIATX
localeus
websitehttps://www.delphiatx.com/
source_refc6af0f43-9c3d-4305-89c5-c24e4180cfb5
products_or_servicesDevelopment of cancer therapeutics
United States